AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
What is it?
Maraviroc (or Celsentri) is an HIV medication, the first of its kind. Maraviroc doesn't block HIV directly; instead, maraviroc binds to a human protein known as CCR5. This is one of the proteins HIV uses to enter human T cells. By binding to CCR5, maraviroc keeps HIV from infecting T cells.
Who's it for?
Maraviroc, in combination with other HIV meds, is indicated for treatment-experienced adults infected with CCR5-tropic (attracted to something specified) HIV.
What does that mean?
In order for HIV to infect a T cell, the virus must first latch onto a receptor (nerve ending), called CD4, on the cell's surface. Researchers have known for a long time that HIV needs a second receptor on the CD4 receptor to enter the T cell. The others receptors that it uses are CCR5 and CXCR4, with CCR5 being the most common. The new drug, maraviroc, has the ability to block HIV that uses CCR5, but not HIV that uses CXCR4. This is the first time that a treatment for HIV is targeting a function of the cells in the body, not the virus itself.
How do I know what kind of virus I have?
Source: HighBeam Research, New drug profile: Maraviroc: it's different, it's strong, and it's...